COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR and Serum Institute of India https://ift.tt/eA8V8J

The ICMR funded the clinical trial site fees while the SII provided the other expenses for the vaccine, said a release.

from The Hindu - National https://ift.tt/3njd2Ia